Male hypogonadism: More than just a low testosterone

Cleveland Clinic Journal of Medicine

Volumn 79, Issue 10, 2012, Pages 717-725

  Pantalone, Kevin M ^a   Faiman, Charles ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE;

BLOOD; CASE REPORT; CIRCADIAN RHYTHM; EUNUCHOIDISM; HUMAN; MALE; MIDDLE AGED; REVIEW; TIME;

CIRCADIAN RHYTHM; EUNUCHISM; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MALE; MIDDLE AGED; TESTOSTERONE; TIME FACTORS;

EID: 84870266501     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.79a.11174     Document Type: Review

References (48)

1. Pitteloud N, Dwyer AA, De Cruz S, et al. Inhibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypo-thalamic effects: evidence from the tandem study of normal and gonadotropin-releasing hormonedeficient men. J Clin Endocrinol Metab 2008;93:784-791.
2. Hayes FJ, De Cruz S, Seminara SB, Boepple PA, Crowley WF Jr. Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion. J Clin Endocrinol Metab 2001;86:53-58.
3. Hayes FJ, Pitteloud N, De Cruz S, Crowley WF Jr, Boepple PA. Importance of inhibin B in the regulation of FSH secretion in the human male. J Clin Endocrinol Metab 2001;86:5541-5546.
4. Pitteloud N, Dwyer AA, De Cruz S, et al. The relative role of gonadal sex steroids and gonadotropin-releasing hormone pulse frequency in the regulation of follicle-stimulating hormone secretion in men. J Clin Endocrinol Metab 2008;93:2686-2692.
5. Cooke RR, Mcintosh JE, Mcintosh RP. Circadian variation in serum free and non-SHBG-bound testosterone in normal men: measurements, and simulation using a mass action model. Clin Endocrinol (Oxf) 1993;39:163-171.
6. Diver MJ, Imtiaz KE, Ahmad AM, Vora JP, Fraser WD. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol (Oxf) 2003;58:710-717.
7. Clair P, Claustrat B, Jordan D, Dechaud H, Sassolas G. Daily variations of plasma sex hormone-binding globulin binding capacity, testosterone and luteinizing hormone concentrations in healthy rested adult males. Horm Res 1985;21:220-223.
8. Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M. Transient hypogonadotropic hypogonadism caused by critical illness. J Clin Endocrinol Metab 1985;60:444-450.
9. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007;92:405-413.
10. Rosner W, Vesper H; Endocrine Society; American Association for Clinical Chemistry; American Association of Clinical Endocrinologists; et al. Toward excellence in testosterone testing: a consensus statement. J Clin Endocrinol Metab 2010;95:4542-4548.
11. Bhasin S, Cunningham GR, Hayes FJ, et al; Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010;95:2536-2559.
12. Wu FC, Tajar A, Beynon JM, et al; EMAS Group. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010;363:123-135.
13. Farrer JH, Sikka SC, Xie HW, Constantinide D, Rajfer J. Impaired testosterone biosynthesis in cryptorchidism. Fértil Steril 1985;44:125-132.
14. Sikka SC, Swerdloff RS, Rajfer J. In vitro inhibition of testosterone biosynthesis by ketoconazole. Endocrinology 1985;116:1920-1925.
15. ™ (Internet). Seattle, WA: University of Washington; 1993.
16. Chevrier L, Guimiot F, de Roux N. GnRH receptor mutations in isolated gonadotropic deficiency. Mol Cell Endocrinol 2011;346:21-28.
17. Romero CI, Pine-Twaddell E, Radovick S. Novel mutations associated with combined pituitary hormone deficiency. J Mol Endocrinol 2011;46:R93-R102.
18. Colameco S, Coren JS, Ciervo CA. Continuous opioid treatment for chronic noncancer pain: a time for moderation in prescribing. Postgrad Med 2009;121:61-66.
19. Fraser LA, Morrison D, Morley-Forster P, et al. Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women. Exp Clin Endocrinol Diabetes 2009;117:38-43.
20. Morrison D, Capewell S, Reynolds SP, et al. Testosterone levels during systemic and inhaled corticosteroid therapy. Respir Med 1994;88:659-663.
21. Mah PM, Wittert GA. Obesity and testicular function. Mol Cell Endocrinol 2010;316:180-186.
22. Grossmann M. Low testosterone in men with type 2 diabetes: significance and treatment. J Clin Endocrinol Metab 2011;96:2341-2353.
23. Gascón F, Valle M, Martos R, et al. Sex hormone-binding globulin as a marker for hyperinsulinemia and/or insulin resistance in obese children. Eur J Endocrinol 2000;143:85-89.
24. Dhindsa S, Miller MG, McWhirter CL, et al. Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care 2010;33:1186-1192.
25. Grossmann M, Gianatti EJ, Zajac JD. Testosterone and type 2 diabetes. Curr Opin Endocrinol Diabetes Obes 2010;17:247-256.
26. Andersson B, Márin P, Lissner L, Vermeulen A, Bjórntorp P. Testosterone concentrations in women and men with NIDDM. Diabetes Care 1994;17:405-411.
27. Santamaria JD, Prior JC, Fleetham JA. Reversible reproductive dysfunction in men with obstructive sleep apnoea. Clin Endocrinol (Oxf) 1988;28:461-470.
28. Grunstein RR, Handelsman DJ, Lawrence SJ, Blackwell C, Caterson ID, Sullivan CE. Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy. J Clin Endocrinol Metab 1989;68:352-358.
29. Matsumoto AM, Sandblom RE, Schoene RB, et al. Testosterone replacement in hypogonadal men: effects on obstructive sleep apnoea, respiratory drives, and sleep. Clin Endocrinol (Oxf) 1985;22:713-721.
30. Bremner WJ, Vitiello MV, Prinz PN. Loss of arcadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab 1983;56:1278-1281.
31. McDermott JH, Walsh CH. Hypogonadism in hereditary hemochromatosis. J Clin Endocrinol Metab 2005;90:2451-2455.
32. Kelly TM, Edwards CQ, Meikle AW, Kushner JP. Hypogonadism in hemochromatosis: reversal with iron depletion. Ann Intern Med 1984;101:629-632.
33. Milenkovic L, D'Angelo G, Kelly PA, Weiner RI. Inhibition of gonadotropin hormone-releasing hormone release by prolactin from GT1 neuronal cell lines through prolactin receptors. Proc Natl Acad Sci U S A 1994;91:1244-1247.
34. Valensi P, Coussieu C, Kemeny JL, Attali JR, Amouroux J, Sebaoun J. Endocrine investigations in two cases of feminizing Leydig cell tumour. Acta Endocrinol (Copenh) 1987;115:365-372.
35. Young S, Gooneratne S, Straus FH 2nd, Zeller WP, Bulun SE, Rosenthal IM. Feminizing Sertoli cell tumors in boys with Peutz-Jeghers syndrome. Am J Surg Pathol 1995;19:50-58.
36. Zayed A, Stock JL, Liepman MK, Wollin M, Longcope C. Feminization as a result of both peripheral conversion of androgens and direct estrogen production from an adrenocortical carcinoma. J Endocrinol Invest 1994;17:275-278.
37. Russ MJ, Ackerman SH, Barakat R, Levy B. Hypogonadotropic hypogonadism and delayed puberty in a man with anorexia nervosa. Psychosomatics 1986;27:737-739.
38. Rigotti NA, Neer RM, Jameson L. Osteopenia and bone fractures in a man with anorexia nervosa and hypogonadism. JAMA 1986;256:385-388.
39. Cohan GR. HIV-assoclated hypogonadism. AIDS Read 2006;16:341-345, 348, 352-354.
40. Handelsman DJ, Strasser S, McDonald JA, Conway AJ, McCaughan GW. Hypothalamic-pituitary-testicular function in end-stage nonalcoholic liver disease before and after liver transplantation. Clin Endocrinol (Oxf) 1995;43:331-337.
41. Lim VS, Fang VS. Gonadal dysfunction in uremic men. A study of the hypothalamo-pituitary-testicular axis before and after renal transplantation. Am J Med 1975;58:655-662.
42. Handelsman DJ, Dong Q. Hypothalamo-pituitary gonadal axis in chronic renal failure. Endocrinol Metab Clin North Am 1993;22:145-161.
43. Handelsman DJ, Spaliviero JA, Turtle JR. Hypothalamic-pituitary function in experimental uremic hypogonadism. Endocrinology 1985;117:1984-1995.
44. Tengstrand B, Carlstrdm K, Hafstrom I. Bioavailable testosterone in men with rheumatoid arthritis-high frequency of hypogonadism. Rheumatology (Oxford) 2002;41:285-289.
45. Tengstrand B, Carlstrdm K, Hafstrom I. Gonadal hormones in men with rheumatoid arthritis-from onset through 2 years. J Rheumatol 2009;36:887-892.
46. Emanuele MA, Emanuele NV. Alcohol's effects on male reproduction. Alcohol Health Res World 1998;22:195-201.
47. Meikle AW. The interrelationships between thyroid dysfunction and hypogonadism in men and boys. Thyroid 2004;14(suppl 1):S17-S25.
48. Vagenakis AG, Dole K, Braverman LE. Pituitary enlargement, pituitary failure, and primary hypothyroidism. Ann Intern Med 1976;85:195-198.